Showing 221-230 of 20328 results for "".
- Neurology and Neurosurgery - Industry Featurehttps://reachmd.com/industry-feature/neurology-and-neurosurgery/
- Medical Industry Feature - Programshttps://reachmd.com/programs/medical-industry-feature/
- Allergy and Clinical Immunology - Clinical Practicehttps://reachmd.com/clinical-practice/allergy-and-clinical-immunology/
- FAQs with Key Opinion Leaders - Expert Perspectiveshttps://reachmd.com/expert-perspectives/faqs-with-key-opinion-leaders/Join experts as they discuss key developments, targeted therapies and the role of immunotherapy.
Type I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure-1/1022/Dr. Jerry Nadler, Professor of Medicine, Chief of the Division of Endocrinology and Metabolism and Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA discusses his Type I diabetes research looking for a two-drug cure.Management of Type I Diabetes in Young Children
https://reachmd.com/programs/focus-on-diabetes/management-of-type-i-diabetes-in-young-children/3840/Over 40 children a day are diagnosed with type I diabetes in the United States. What are the clinical management issues pediatric practitioners face today? Joining host Dr. Mary Leuchars is Dr. H. Peter Chase, professor of pediatrics at the University of Colorado Health Sciences Center and past-execType I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure/1020/Dr. Raghu Mirmira, Associate Professor of Medicine and Associate Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA is here to discuss his work with transcription factors, the timing of their expression, the genes they taThe Potential of Immunotherapy in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/the-potential-of-immunotherapy-in-type-1-diabetes/5111/Development of a combination therapy is showing significant promise in type 1 diabetes when caught in the early stages. What are some immuno-therapies currently being evaluated for treating type 1 diabetes? Join host Dr. Steven Edelman and his guest, director of the Center for Type 1 Diabetes ResearIdentification and Management of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/identification-and-management-of-type-1-diabetes/308/Dr. Lori Laffel will discuss the increase in prevelence of Type 1 diabetes. She will also talk about the importance of glycemic control.Intensive Therapy for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/intensive-therapy-for-type-1-diabetes/326/Dr. Lori Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses intesive therapy for Type 1 diabetes.